Sick Money
New
Indicative market price: R330
Shipping
Standard courier shipping from R30
R30 Standard shipping using one of our trusted couriers applies to most areas in South Africa. Some areas may attract a R30 surcharge. This will be calculated at checkout if applicable.
Check my rate
Check my rate
Collect from a locker or counter from R5
There are various locker and counter collection points across South Africa.
View locations
View locations
Ready to ship in
The seller has indicated that they will usually have this item
ready to ship within 2 business days. Shipping time depends on your delivery address. The most
accurate delivery time will be calculated at checkout, but in
general, the following shipping times apply:
Standard Delivery
| Main centres: | 1-3 business days |
| Regional areas: | 3-4 business days |
| Remote areas: | 3-5 business days |
Get it now, pay later
Seller
Buyer Protection
Product details
Condition
New
Location
South Africa
Product code
9781838850265
Bob Shop ID
594326339
The pharmaceutical industry is broken. From the American hedge fund manager who hiked the price of an AIDS pill from $17.50 to $750 overnight to the children's cancer drugs left intentionally to expire in a Spanish warehouse, the signs of this dysfunction are all around. A system that was designed to drive innovation and patient care has been relentlessly distorted to drive up profits.
Medicines have become nothing more than financial assets. The focus of drug research, how drugs are priced and who has access to them is now dictated by shareholder value, not the good of the public. Drug companies fixated on ever-higher profits are being fined for bribing doctors and striking secret price-gouging deals, while patients desperate for life-saving medicines are driven to the black market in search of drugs that national health services can't afford.
Sick Money argues that the way medicines are developed and paid for is no longer working. Unless we take action we risk a dramatic decline in the pace of drug development and a future in which medicines are only available to the highest bidder. In this book investigative journalist Billy Kenber offers a diagnosis of an industry in crisis and a prescription for how we can fight back.
Medicines have become nothing more than financial assets. The focus of drug research, how drugs are priced and who has access to them is now dictated by shareholder value, not the good of the public. Drug companies fixated on ever-higher profits are being fined for bribing doctors and striking secret price-gouging deals, while patients desperate for life-saving medicines are driven to the black market in search of drugs that national health services can't afford.
Sick Money argues that the way medicines are developed and paid for is no longer working. Unless we take action we risk a dramatic decline in the pace of drug development and a future in which medicines are only available to the highest bidder. In this book investigative journalist Billy Kenber offers a diagnosis of an industry in crisis and a prescription for how we can fight back.